Antibiotic-resistant Bacterial Infection of Hepatic Patients

2019-03-05 02:29:15 | BioPortfolio

Published on BioPortfolio: 2019-03-05T02:29:15-0500

Clinical Trials [2230 Associated Clinical Trials listed on BioPortfolio]

Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy

The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of imp...

Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives

Throughout project, the investigators design, evaluate and disseminate infection control and antibiotic stewardship (ABS) measures aimed at reducing the incidence of Clostridium difficile ...

Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT)

Patients with negative blood cultures represent 85-90 % from all patients with a blood culture taken during hospital admissions. This population usually includes an heterogeneous group of ...

Antibiotic Resistant Community-Acquired E. Coli

The purpose of this study is to review patients with E. coli infections at UPMC from January 1, 2004 to December 31, 2005 to determine if these infections have arisen in the community rath...

Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients

This study will compare two treatment strategies (standard versus short-course antibiotic therapy) for preventing resistant bacterial infection in patients in the intensive care unit (ICU)...

PubMed Articles [12970 Associated PubMed Articles listed on BioPortfolio]

Is sonication of antibiotic-loaded cement spacers useful in two-stage revision of prosthetic joint infection?

In a two-stage exchange protocol for prosthetic joint infection (PJI), bacteria surviving over the antibiotic-loaded cement spacers may cause the persistence of infection with renewed clinical symptom...

Bone Flap Necrosis due to Low Grade Infection with Propionibacterium Acnes.

Osteonecrosis of bone flaps after cranioplasty with autologeous cryo-conserved bone flaps is a common phenomenon. The exact reason for it remains unknown. We present a case of a 67-year old patient wh...

Changes in Microbial Profiles and Antibiotic Resistance Patterns in Patients with Biliary Tract Infection Over a Six-Year Period.

Biliary tract infection (BTI) is a common complication in patients with biliary obstruction caused by various biliary tract disorders. To improve the management of patients with BTI, microbial profile...

Ten-year analysis of microbiological profile and antibiotic sensitivity for bacterial keratitis in Korea.

To investigate the risk factors, microbiological profiles, antibiotic susceptibility patterns, and treatment outcome in patients with bacterial keratitis at a Korean tertiary hospital.

Spatial and temporal variation of antibiotic resistance in marine fish cage-culture area of Guangdong, China.

The rapid emergence and dissemination of antibiotic resistance poses a threat to human health and to the marine environment. We have investigated the abundance and diversity of antibiotic resistance g...

Medical and Biotech [MESH] Definitions

Strains of the genus Enterococcus that are resistant to the antibiotic VANCOMYCIN. The enterococci become resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE.

A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.

An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.

A semisynthetic cephamycin antibiotic resistant to beta-lactamase.

A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.

More From BioPortfolio on "Antibiotic-resistant Bacterial Infection of Hepatic Patients"

Quick Search


Searches Linking to this Trial